prognostic indicators

News

Risk Score to Predict Early Infection in Patients With Multiple Myeloma

06/26/2020

A post-hoc analysis presented at the European Hematology Association (EHA) Annual Meeting (June 11-21, 2020) led to a new risk prediction score for early severe infection in patients with multiple myeloma. Many...

A...

06/26/2020

Journal of Clinical Pathways

News

Late-Stage Melanoma Prognosis After Treatment With Novel Therapies

06/18/2020

Melanoma-specific survival rates in the Central Malignant Melanoma Registry (CMMR) and European Organization for Research and Treatment of Cancer (EORTC) stage III data sets are less favorable than those published in...

...

06/18/2020

Journal of Clinical Pathways

News

Modified MIPI Scoring System Provides Clinical, Biological Prognostic Indicators for MCL

06/11/2020

At the American Society of Clinical Oncology (ASCO) Annual Meeting (May 29-31, 2020), researchers from the North American Mantle Cell Lymphoma (MCL) Consortium offered clinical, biological, and genomic markers that...

At the...

06/11/2020

Journal of Clinical Pathways

Research in Review

Resistance Mutations Predict Metastatic Patterns in NSCLC

08/17/2017

JCP Editors

Specific gene rearrangements associated with increased resistance to standard therapy may predict different metastasis distributions in patients with non-small cell lung cancer (NSCLC), according to research...

...

08/17/2017

Journal of Clinical Pathways

Research in Review

Novel Prostate Cancer Biomarkers May Improve Targeted Therapy

08/15/2017

JCP Editors

Recent research has uncovered a new cause of treatment resistance in prostate cancer, which may improve targeted therapy efforts. Mutations within the SPOP gene are the most frequently documented genetic changes in...

Recent...

08/15/2017

Journal of Clinical Pathways

Research in Review

Predicting Survival, Treatment Response in Patients With Follicular Lymphoma

08/14/2017

JCP Editors

A recent study suggests a variable that should be used as a standard outcome measure for clinical trials of patients with follicular lymphoma, published in the British Journal of Hematology (online August 7, 2017;...

A...

08/14/2017

Journal of Clinical Pathways

Research in Review

Lymphocyte Biomarkers Predict PFS in HER2-Positive Breast Cancer

07/31/2017

JCP Editors

A low level of stromal cytotoxic T-cell infiltration in breast cancer tumor specimens predicts patients who may benefit most from antibody- vs molecular-based human epidermal growth factor receptor 2 (HER2)...

A low...

07/31/2017

Journal of Clinical Pathways

Research in Review

NSCLC Prognostic Index Considers Personal Characteristics to Better Predict Outcomes

07/26/2017

JCP Editors

The Lung Cancer Prognostic Index provides personalized and disease-specific prognostic information for patients with non-small cell lung cancer (NSCLC) and may result in better survival outcomes, according to a...

The...

07/26/2017

Journal of Clinical Pathways

Research in Review

Prognostic Implications of ETS2 Expression in AML

07/25/2017

JCP Editors

Elevated expression levels of ETS2 were a strong predictor of prognosis in acute myeloid leukemia (AML) and should be used to guide treatment decisions, according to recent research published in Journal of...

...

07/25/2017

Journal of Clinical Pathways

Research in Review

Novel Prognostic Index Designed for Patients With MZL

07/19/2017

JCP Editors

A new prognostic tool improves personalized treatment for patients with marginal zone lymphoma (MZL), according to recent research published in Blood (online July 2017;...

A new...

07/19/2017

Journal of Clinical Pathways